Photo of Robert Hess

Robert Hess

After 12 years in-house advising a major university’s health system and health schools, Robert counsels academic medical centers and other healthcare clients on regulatory compliance matters. He provides health systems and healthcare providers with advice regarding state and federal regulatory requirements, including licensure, reimbursement rules, Medicaid and Medicare requirements, medical staff privileging and credentialing, Stark Law and Anti-Kickback compliance, 340B program matters, and graduate medical education requirements.

Contact:Read more about Robert Hess
Blog SeriesConference Post (1)

This is the third in a series of articles designed to provide SXSW and LSI USA ’26 attendees and other MedTech professionals with practical considerations for efficiently executing mission-critical life science deals. On March 15, during SXSW, Husch Blackwell’s healthcare team will host two panels, bringing together founders and investors from healthcare, technology, and early-stage companies for candid discussion, practical insights, and plenty of time to connect.

Register here.

Judge's gavel on table in office

A federal judge has issued a preliminary injunction halting the Department of Health and Human Services’ (HHS) 340B Rebate Model Pilot Program, which was scheduled to take effect on January 1, 2026. The December 29, 2025 ruling temporarily prevents implementation of the rebate program that would have fundamentally changed how safety-net hospitals and clinics purchase discounted drugs under the 340B Drug Pricing Program.